Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: The HyperGEN study

American Journal of Hypertension

Volumn 15, Issue 12, 2002, Pages 1029-1035

  Devereux, Richard B ^a   De Simone, Giovanni ^a   Palmieri, Vittorio ^a   Oberman, Albert ^b   Hopkins, Paul ^c   Kitzman, Dalane W ^d   Rao, Dabeeru C ^e   Arnett, Donna K ^f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Echocardiography; Hypertension; Insulin; Left ventricle

Indexed keywords

INSULIN; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY SIZE; CAUCASIAN; ETHNIC DIFFERENCE; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART RATE; HEART STROKE VOLUME; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; SEX DIFFERENCE; BLOOD; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; ETHNOLOGY; MIDDLE AGED; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BODY MASS INDEX; ECHOCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN; MALE; MIDDLE AGED; UNITED STATES;

EID: 0036893605     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03080-7     Document Type: Article

References (41)

1. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ: The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845-855.
2. Liang C, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB Jr: Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest 1982;69:1321-1336.
3. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246-2252.
4. Devereux RB, Roman MJ, de Simone G, O'Grady MJ, Paranicas M, Yeh J-L, Fabsitz RR, Howard BV, for the Strong Heart Study Investigator: Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: The Strong Heart Study. Circulation 1997;96:1416-1423.
5. Hartford M, Wikstrand J, Wallentin I, Ljungman S, Wilkelmsen L, Berglund G: Left ventricular mass in middle-aged men. Relationship to blood pressure, sympathetic nervous activity, hormonal and metabolic factors. Clin Exp Hypertens 1983;5:1429-1451.
6. Sharp SD, Williams RR: Fasting insulin and left ventricular mass in hypertensives and normotensive controls. Cardiology 1992;81:207-212.
7. Sasson Z, Rasooly Y, Bhesania T, Rasooly I: Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993;88:1431-1436.
8. Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S: Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994;90:928-936.
9. Lind L, Andersson PE, Andren B, Hanni A. Lithell HO: Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995;13:433-438.
10. Costa CH, Batista MC, Moises VA, Kohlmann NB, Ribeiro AB, Zanella MT: Serum insulin levels, 24-hour blood pressure profile, and left ventricular mass in nonobese hypertensive patients. Hypertension 1995;26:1085-1088.
11. Ohya Y, Abe I, Fujii K, Ohmori S, Onaka U, Kobayashi K, Fujishima M: Hyperinsulinemia and left ventricular geometry in a work-site population in Japan. Hypertension 1996;27:729-734.
12. Paolisso G, Galderisi M, Tagliamont MR, de Divitis M, Galzerano D, Petrocelli A, Gualdiero P, de Divitis O, Varricchio M: Myocardial wall thickness and left ventricular geometry in hypertensives: Relation with insulin. Am J Hypertens 1997;10:1250-1256.
13. Vetta F, Cicconetti P, Ronzoni S, Rizzo V, Palleschi L, Canarile G, Lupattelli MR, Migliori M, Morelli S, Marigliano V: Hyperinsulinaemia, regional adipose tissue distribution and left ventricular mass in normotensive, elderly, obese subjects. Eur Heart J 1998;19:326-331.
14. Jelenc M, Zemva A, Marn-Pernat A, Zemva Z: Are insulin metabolism and night-time blood pressure related to left ventricular hypertrophy? Int J Cardiol 1998;63:261-265.
15. Gutin B, Treiber F, Owens S, Mensah GA: Relations of body composition to left ventricular geometry and function in children. J Pediatr 1998;132:1023-1027.
16. Phillips RA, Krakoff LR, Dunaif A, Finegood D, Gorlin R, Shimabukuro S: Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. J Clin Endocrinol Metab 1998;83:4284-4288.
17. Scuteri A, Di Bernardo MG, De Propris AM, Marigliano V: Insulin effects on the left ventricle in older hypertensive subjects. J Am Geriatr Soc 1999;47:727-729.
18. Urbina EM, Gidding SS, Bao W, Elkasabany A, Berenson GS: Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: The Bogalusa Heart Study. Am Heart J 1999;138:122-127.
19. Rheeder P, Stolk RP, Mosterd A, Pols HA, Hofman A, Grobbee DE: Insulin resistance syndrome and left ventricular mass in an elderly population (the Rotterdam Study). Am J Cardiol 1999;84:233-366.
20. Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H, Miyagawa M, Kohara K: Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. J Hypertens 1999;17:1161-1168.
21. Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP, Santeusanio G, Porcellati C, Brunetti P: Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999;100:1802-1807.
22. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Howard BV: Associations of insulin levels with left ventricular structure and function in American Indians: The Strong Heart Study. Diabetes 2002;51:1543-1547.
23. Williams RR, Rao DC, Ellison RC, Arnett DK, Heiss G, Oberman A, Eckfeldt JH, Leppert MF, Province MA, Mockrin SC, Hunt SC: NHLBI family blood pressure program: Methodology and recruitment in the HyperGEN network. Ann Epidemiol 2000;10:389-400.
24. Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, Rao DC, Sprafka JM, Williams R: The NHLBI Family Heart Study: Objectives and design. Am J Epidemiol 1996;143:1219-1228.
25. American Diabetes Association: Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-1197.
26. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Wood EA, Howard BV, Welty TK, Lee ET, Fabsitz RR: Relations of Doppler stroke distance and aortic anular diameter to left ventricular stroke volume in normotensive and hypertensive American Indians: The Strong Heart Study. Am J Hypertens 1997;10:619-628.
27. Devereux RB, Roman MJ: Evaluation of cardiac and vascular structure by echocardiography and other noninvasive techniques, in Laragh JH, Brenner BM (eds) Hypertension: Pathophysiology, Diagnosis, Treatment. 2nd Ed. Raven Press, New York, 1995, pp 1969-1985.
28. Sahn DJ, De Maria A, Kisslo J, Weyman A: The Committee on M-mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
29. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-367.
30. Shiina A, Tajik AJ, Smith HC, Lengyel M, Seward JB: Prognostic significance of regional wall motion abnormality in patients with prior myocardial infarction: A prospective correlative study of two-dimensional echocardiography and angiography. Mayo Clin Proc 1986;61:254-262.
31. Palmieri V, Dahlöf B, DeQuattro V, Sharpe N, Bella JN, de Simone G, Paranicas M, Fishman D, Devereux RB: Reliability of echocardiographic assessment of left ventricular structure and function: The PRESERVE Study. J Am Coll Cardiol 1999;34:1625-16.
32. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
33. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in men and women with essential hypertension. Ann Intern Med 1991;114:345-352.
34. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB: Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999;131:564-572.
35. Teichholz LE, Kreulen T, Herman MV, Gorlin R: Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976;37:7-11.
36. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH: Assessment of left ventricular function by the mid-wall fractional shortening-end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994;23:1444-1451.
37. Gaasch WH, Zile MR, Hoshino PK, Apstein CS, Blaustein AS: Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 1989;79:872-873.
38. Devereux RB, de Simone G, Pickering TG, Schwartz JE, Roman MJ: Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension 1998;3I:929-936.
39. De Fronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;12:173-194.
40. Kaplan NM: The deadly quarter and the insulin resistance syndrome and historical overview. Hypertens Res 1996;19(Suppl 1):S9-S11.
41. Galvan AQ, Galetta F, Natali A, Muscelli E, Sironi AM, Cini G, Camastra S, Ferrannini E: Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans. Circulation 2000;102:2233-2238.